INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

INVO Fertility (NASDAQ: IVF) is a medical technology and fertility services company specializing in in vitro fertilization (IVF) and assisted reproductive treatments. Established to broaden access to fertility care, the company develops innovative culture systems, diagnostic tools and clinical offerings designed to improve patient outcomes and reduce the complexity and cost traditionally associated with IVF. INVO Fertility’s proprietary device, the INVOcell® Intravaginal Culture (IVC) system, allows for embryo development within a patient’s body, offering an alternative to conventional laboratory incubation.

INVO Fertility’s product portfolio includes the INVOcell® device, complementary culture media, cryopreservation supplies and patient monitoring technologies. In addition to its core IVC system, the company provides training programs and partner support services for fertility clinics, helping practitioners integrate the INVOcell® platform into their treatment protocols. This integrated approach aims to streamline laboratory workflow, improve patient satisfaction and expand the availability of IVF services in lower-resource settings.

With its headquarters in Dania Beach, Florida, INVO Fertility serves a global customer base of reproductive clinics, hospitals and physician networks. The company has established distribution partnerships in North America, Latin America, Europe and select Asian markets, tailoring training curricula and regulatory support to meet regional requirements. Through collaboration with academic institutions and specialty fertility centers, INVO Fertility continues to explore clinical studies and real-world evidence to validate the safety and efficacy of its IVC technology.

INVO Fertility’s executive leadership team brings together experts in reproductive medicine, medical device commercialization and healthcare operations. The board of directors includes clinicians and industry veterans who guide corporate strategy, regulatory affairs and product development. Under this leadership, the company remains focused on advancing patient-centric fertility solutions, expanding global access to assisted reproductive technologies, and fostering long-term relationships with healthcare providers.

Key Stats

• Today's Range: $0.83 to $0.92
• 50-Day Range: $0.78 to $2.18
• 52-Week Range: $0.74 to $17.04
• Volume: 923,334 shs
• Average Volume: 606,607 shs
• Market Capitalization: $1.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVF Stock Analysis - Frequently Asked Questions

How have IVF shares performed this year?

INVO Fertility's stock was trading at $2.18 at the beginning of the year. Since then, IVF shares have decreased by 61.5% and is now trading at $0.84.

How were INVO Fertility's earnings last quarter?

INVO Fertility, Inc (NASDAQ:IVF) issued its quarterly earnings data on Tuesday, May, 20th. The company reported ($12.53) earnings per share for the quarter. The company earned $1.64 million during the quarter.

When did INVO Fertility's stock split?

INVO Fertility's stock reverse split on Monday, July 21st 2025.The 1-3 reverse split was announced on Thursday, July 17th 2025. The number of shares owned by shareholders will be adjusted after the market closes on Friday, July 18th 2025. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

How do I buy shares of INVO Fertility?

Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/20/2025
• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IVF
• CIK: 1417926
• Web: N/A
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($34.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.10 million
• Net Margins: -377.73%
• Pretax Margin: -378.10%
• Return on Equity: N/A
• Return on Assets: -88.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $6.53 million
• Price / Sales: 0.28
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($29.86) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 2,160,000
• Free Float: 2,149,000
• Market Cap: $1.81 million
• Optionable: N/A
• Beta: 2.04